Novel biomarkers for the prediction of COVID-19 progression a retrospective, multi-center cohort study
A pandemic designated as Coronavirus Disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is spreading worldwide. Up to date, there is no efficient biomarker for the timely prediction of the disease progression in patients. To analyze the inflammatory profi...
Enregistré dans:
| Auteurs principaux: | Yalan Yu, Tao Liu, Liang Shao, Xinyi Li, Colin K. He, Muhammad Jamal, Yi Luo, Yingying Wang, Yanan Liu, Yufeng Shang, Yunbao Pan, Xinghuan Wang, Fuling Zhou |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
Taylor & Francis Group
2020
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/aeda50ee6d614fe1a96874fcbbb71bde |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Muscle MRI as a Useful Biomarker in Hereditary Transthyretin Amyloidosis: A Pilot Study
par: Guido Primiano, et autres
Publié: (2021) -
Salivary Biomarkers in Alzheimer´s Disease
par: Santos,Gustavo A. A, et autres
Publié: (2020) -
Role of Serum Uromodulin in the Early Diagnosis of Chronic Kidney Disease
par: Genov D., et autres
Publié: (2021) -
The interrelationship of bone and cardiovascular remodeling biomarkers and clinical peculiarities of coronary artery disease in postmenopausal women
par: Natalia Serhiivna Mykhailovska, et autres
Publié: (2020) -
The Macrophage Reprogramming Ability of Antifolates Reveals Soluble CD14 as a Potential Biomarker for Methotrexate Response in Rheumatoid Arthritis
par: Sara Fuentelsaz-Romero, et autres
Publié: (2021)